Essential tremor: differential diagnosis and current therapy

Am J Med. 2003 Aug 1;115(2):134-42. doi: 10.1016/s0002-9343(03)00259-6.

Abstract

Essential tremor is a common movement disorder that affects between 5 and 10 million persons in the United States. It is characterized primarily by an action and postural tremor most often affecting the arms, but it can also affect other body parts. Essential tremor is a progressive neurologic disorder and can cause substantial disability in some patients. Although there is no cure for essential tremor, pharmacologic and surgical treatments can provide some benefit. Primidone and propranolol are first-line treatments. Other medications with potential efficacy include benzodiazepines, gabapentin, topiramate, and botulinum toxin. Patients with medication-resistant tremor may benefit from thalamotomy or deep brain stimulation of the thalamus. The use of medical and surgical therapies can provide benefit in up to 80% of patients with essential tremor.

Publication types

  • Review

MeSH terms

  • Acetates / therapeutic use
  • Adrenergic beta-Antagonists / therapeutic use
  • Amines*
  • Anti-Dyskinesia Agents / therapeutic use
  • Anticonvulsants / therapeutic use
  • Benzodiazepines / therapeutic use
  • Botulinum Toxins / therapeutic use
  • Cyclohexanecarboxylic Acids*
  • Diagnosis, Differential
  • Electric Stimulation Therapy / methods
  • Essential Tremor / diagnosis*
  • Essential Tremor / therapy*
  • Ethanol / therapeutic use
  • Fructose / analogs & derivatives*
  • Fructose / therapeutic use
  • Gabapentin
  • Humans
  • Primidone / therapeutic use
  • Thalamus / surgery
  • Topiramate
  • gamma-Aminobutyric Acid*

Substances

  • Acetates
  • Adrenergic beta-Antagonists
  • Amines
  • Anti-Dyskinesia Agents
  • Anticonvulsants
  • Cyclohexanecarboxylic Acids
  • Topiramate
  • Benzodiazepines
  • Primidone
  • Fructose
  • Ethanol
  • gamma-Aminobutyric Acid
  • Gabapentin
  • Botulinum Toxins